A high prevalence of human T-lymphotropic virus (HTLV 1/2) infection among Afro-descendants, Esmeraldas province, Ecuador – need for the implementation of surveys and control programs

References

• de The ´ G, Bomford R. An HTLV-I vaccine: why, how, for whom? AIDS Res Hum Retroviruses. 1993;9(5):381–386. doi:10.1089/aid.1993.9.1598318266
   PubMed Web of Science ®Google Scholar
• European Centre for Disease Prevention and Control. Geographical Distribution of Areas with a High Prevalence of HTLV-1 Infection. Stockholm: ECDC; 2015.
   Google Scholar
• Gessain A, Cassar O. Epidemiological aspects and world distribution of HTLV-1 infection. Front Microbiol. 2012;3:388. doi:10.3389/fmicb.2012.0038823162541
   PubMed Web of Science ®Google Scholar
• Murphy EL, Cassar O, Gessain A. Estimating the number of HTLV-2 infected persons in the world. Retrovirology. 2015;12(Suppl S1):O5. doi:10.1186/1742-4690-12-S1-O5
   Web of Science ®Google Scholar
• Carneiro-Proietti ABF, Catalan-Soares BC, Castro-Costa CM, et al. HTLV in the Americas: challenges and perspectives. Rev Panam Salud Publica. 2006;19(1):44–53. doi:10.1590/S1020-4989200600010000716536938
   PubMed Web of Science ®Google Scholar
• Murphy EL, Wilks R, Hanchard B, et al. A case-control study of risk factors for seropositivity to human T-lymphotropic virus type I (HTLV-I) in Jamaica. Int J Epidemiol. 1996;25(5):1083–1089. doi:10.1093/ije/25.3.5548921498
   PubMed Web of Science ®Google Scholar
• Gotuzzo E, Verdonck K, González E, Cabada M. Virus Linfotrópico humano de células T tipo 1 (HTLV-1): una infección endémica en el Perú. Rev Peru Med Exp Salud Publica. 2004;21(4):253–260.
   Google Scholar
• Alessio L, Minichini C, Starace M, et al. Low prevalence of HTLV1/2 infection in a population of immigrants living in southern Italy. PLoS Negl Trop Dis. 2018;12(6):e0006601. doi:10.1371/journal.pntd.000660129940042
   PubMed Web of Science ®Google Scholar
• Paiva A, Casseb J. Origin and prevalence of human T-lymphotropic virus type 1 (HTLV-1) and type 2 (HTLV-2) among indigenous populations in the Americas. Rev Inst Med Trop Sao Paulo. 2015;57(1):1–13. doi:10.1590/S0036-46652015000100001
   Web of Science ®Google Scholar
• Yoshida M, Seiki M, Yamaguchi K, Takatsuki K. Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease. Proc Natl Acad Sci U S A. 1984;81(8):2534–2537. doi:10.1073/pnas.81.8.25346326131
   PubMed Web of Science ®Google Scholar
• Gessain A, Barin F, Vernant JC, et al. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet. 1985;2(8452):407–410.2863442
   PubMed Web of Science ®Google Scholar
• Goncalves DU, Proietti FA, Ribas JGR, et al. Epidemiology, treatment, and prevention of human T-cell leukemia virus type 1-associated diseases. Clin Microbiol Rev. 2010;23:577–589. doi:10.1128/CMR.00063-0920610824
   PubMed Web of Science ®Google Scholar
• Roucoux DF, Murphy EL. The epidemiology and disease outcomes of human T-lymphotropic virus type II. AIDS Rev. 2004;6:144–154.15595431
   PubMed Web of Science ®Google Scholar
• Proietti FA, Abf C-P, Catalan-Soares BC, Murphy EL. Global epidemiology of HTLV-I infection and associated diseases. Oncogene. 2005;24(39):6058–6068. doi:10.1038/sj.onc.120896816155612
   PubMed Web of Science ®Google Scholar
• Montesdeoca-Andrade MJ, Correa-Diaz EP, Buestán ME. HTLV-1-associated myelopathy in a solid organ transplant recipient. BMJ Case Rep. 2016. doi:10.1136/bcr-2016-215243
   Google Scholar
• Trujillo JM, Concha M, Muñoz A, et al. Seroprevalence and cofactors of HTLV-I infection in Tumaco, Colombia. AIDS Res Hum Retroviruses. 1992;8(5):651–657. doi:10.1089/aid.1992.8.6511515216
   PubMed Web of Science ®Google Scholar
• Domínguez MC, Salcedo M, García-Vallejo F. Serological and virological evaluation of human T-lymphotropic virus type 1 infection in family groups from Tumaco, Colombia. Biomédica. 2015;35:337–346. doi:10.7705/biomedica.v35i3.260126849695
   PubMed Web of Science ®Google Scholar
• Bermúdez-Forero MI, Berrío-Pérez M, Herrera-Hernández AM, et al. Prevalence of human T-cell lymphotropic virus I and II in Colombian blood donors, 2001-2014: implications for transfusion safety. Biomédica. 2016;36(Supl.2):194–200. doi:10.7705/biomedica.v36i0.294327622809
   PubMed Web of Science ®Google Scholar
• Alvarez C, Verdonck K, Tipismana M, Gotuzzo E. A Peruvian family with a high burden of HTLV-1- associated myelopathy/tropical spastic paraparesis. BMJ Case Rep. 2015;bcr2015209619. doi:10.1136/bcr-2015-209619
   Google Scholar
• Guderian R, Guevara A, Cooper P, Rugeles MT, Arango C. HTLV-1 infection and tropical spastic paraparesis in Esmeraldas Province of Ecuador. Trans R Soc Trop Med Hyg. 1994;88:399–400. doi:10.1016/0035-9203(94)90398-07570816
   PubMed Web of Science ®Google Scholar
• Alarcón-Guzmán T, Alarcón-Avilés T. Tratamiento de la Paraparesia Espástica Tropical con Pentoxifilina: estudio Piloto. Rev Neurol. 2002;11(1):1–3.
   Google Scholar
• Alarcón T, Hidalgo C, Aguirre R, Díaz E, Santibáñez R, Navas C. Mielitis Crónica por HTLV-1: resultados en 45 Casos Estudiados. Rev Neurol. 2007;16(3)1–11.
   Google Scholar
• San Martín H, Balanda M, Vergara N, Valenzuela MA, Cartier L, Ayala S, Ramírez E. Human T-Lymphotropic Virus Type 1 and 2 Seroprevalence among first-time blood donors in Chile, 2011-2013. J Med Virol. 2016;88(6):1067–1075. doi:10.1002/jmv.2442826538335
   PubMed Web of Science ®Google Scholar
• Matsumoto C, Mitsunaga S, Oguchi T, et al. Detection of human T-cell leukemia virus type I (HTLV-I) provirus in an infected cell line and in peripheral mononuclear cells of blood donors by the nested double polymerase chain reaction method: comparison with HTLV-I antibody tests. J Virol. 1990;64(11):5290–5294.1976817
   PubMed Web of Science ®Google Scholar
• Gallegos S, Mangano A, Gastaldello R, Sen L, Medeot S. Usefulness of a Nested-polymerase chain reaction for molecular diagnosis of human T-cell lymphotropic virus type I/II. Mem Inst Oswaldo Cruz. 2004;99(4):377–380. doi:10.1590/S0074-0276200400040000615322626
   PubMed Web of Science ®Google Scholar
• Ramirez E, Cartier L, Villota C, Fernandez J. Genetic characterization and phylogeny of human T-cell lymphotropic virus type I from Chile. Virus Res. 2002;84(1–2):135–149. doi:10.1016/S0168-1702(02)00005-911900846
   PubMed Web of Science ®Google Scholar
• Gallo D, Penning LM, Hanson CV. Detection and differentiation of antibodies to human T-cell lymphotropic virus types I and II by the immunofluorescence method. J Clin Microbiol. 1991;29(10):2345–2347.1939596
   PubMed Web of Science ®Google Scholar